Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TMEM97 | Q5BJF2 | 6/20 | 0.83 |
| ▸ | P2RY14 | Q15391 | 15/20 | 0.75 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.63 |
| ▸ | DRD1 | P21728 | 4/20 | 0.61 |
| ▸ | DRD5 | P21918 | 3/20 | 0.59 |
| ▸ | ADRB3 | P13945 | 2/20 | 0.59 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.59 |
| ▸ | DRD3 | P35462 | 2/20 | 0.59 |
| ▸ | HTR1D | P28221 | 1/20 | 0.59 |
| ▸ | HTR1E | P28566 | 1/20 | 0.59 |
| ▸ | TSPO | P30536 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | HTR5A | P47898 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.53 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.53 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.53 |
| ▸ | PDE2A | O00408 | 1/20 | 0.50 |
| ▸ | PDE5A | O76074 | 1/20 | 0.50 |
| ▸ | EGFR | P00533 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30195542 | 0.92 | P2RY14 (0.81) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL2934966 | 0.92 | P2RY14 (0.81) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL29691877 | 0.91 | TMEM97 (1.00) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL13807531 | 0.87 | TMEM97 (0.82) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL2932605 | 0.86 | P2RY14 (1.00) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL13057718 | 0.85 | TMEM97 (0.79) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL29691745 | 0.82 | TMEM97 (0.88) | TMEM97P2RY14SIGMAR1DRD1DRD3 | |
| SCHEMBL3751405 | 0.82 | TMEM97 (0.73) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL21247893 | 0.80 | P2RY14 (0.77) | TMEM97P2RY14SIGMAR1DRD1DRD5 | |
| SCHEMBL22996142 | 0.79 | TMEM97 (0.65) | TMEM97P2RY14SIGMAR1DRD1DRD5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298347-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | MERCK FROSST CANADA LTD (CA) | 2010-11-25 | — | — | US | disclosed |
| US-20100298347-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | MERCK FROSST CANADA LTD (CA) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298347-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | GPR119, GPR52, GPR35 | TMEM97 143/4885P2RY14 423/4885SIGMAR1 2471/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.